Viromed Medical AG Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	7.36	1.17	-	0
Revenue Growth	526.51%	-	-	-
Cost of Revenue	2.8	1.41	-	-
Gross Profit	4.56	-0.24	0	0
Selling, General & Admin	0.86	0.4	0.09	0.04
Depreciation & Amortization Expenses	0.52	0.25	-	-
Other Operating Expenses	4.04	2.61	0.27	0.12
Total Operating Expenses	5.42	3.26	0.36	0.16
Operating Income	-0.87	-3.5	-0.36	-0.16
Interest Income	0.33	0.11	0.25	0
Interest Expense	-0.2	-0.72	-0	-0
Other Non-Operating Income (Expense)	0.04	0	-	-
Total Non-Operating Income (Expense)	0.17	-0.61	0.25	-0
Pretax Income	-0.69	-4.11	-0.11	-0.16
Provision for Income Taxes	-1.3	-1.02	-	-
Net Income	0.57	-3.09	-0.11	-0.16
Net Income to Common	-0.6	3.09	-0.11	-0.16
Net Income Growth	-	-	-	-
Shares Outstanding (Basic)	21	20	20	-
Shares Outstanding (Diluted)	21	20	20	-
Shares Change	4.73%	-	-	-
EPS (Basic)	-0.03	0.15	-0.01	-
EPS (Diluted)	-0.03	0.15	-0.01	-
EPS Growth	-	-	-	-

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Free Cash Flow	3.53	-0.4	0	0
Free Cash Flow Growth	-	-	-	-
Free Cash Flow Per Share	0.17	-0.02	-	-
Gross Margin	61.92%	-20.30%	-	100.00%
Operating Margin	-11.78%	-297.91%	-	-748480.00%
Profit Margin	7.71%	-263.22%	-	-749148.00%
FCF Margin	47.98%	-33.86%	-	0.00%
EBITDA	-0.34	-3.5	-0.36	-0.16
EBITDA Margin	-4.65%	-297.91%	-	-748480.00%
EBIT	-0.87	-3.5	-0.36	-0.16
EBIT Margin	-11.78%	-297.91%	-	-748480.00%
Effective Tax Rate	187.24%	24.89%	0.00%	0.00%